Skip to main content

Pfizer — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

99
Companies
$4.0B
Total invested
$92.6M
Avg. check
24
Industries
Biotechnology 22Therapeutics 11Health Care 10Pharmaceutical 9Biopharma 7Medical 5+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 99
Circle Pharma
September 2024

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

Biotechnology · San Francisco$90.0M Series D
ReCode Therapeutics
September 2025

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Biopharma · Dallas$29.4M Debt Financing
Levicept
September 2021

Levicept develops biological agent for the treatment of chronic pain.

Biopharma · Sandwich$47.8M Series B
Anjarium Biosciences
September 2021

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

Biotechnology · Schlieren$60.4M Series A
Resistell AG
September 2025

Resistell is a antibiotic resistance test.

Health Diagnostics · BaselGrant
Strata Oncology
July 2021

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Biotechnology · Ann Arbor$90.0M Series C
Dren Bio
July 2024

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Biotechnology · Foster City$25.0M Corporate Round
Spero Therapeutics
July 2026

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Biotechnology · Cambridge$105.0M Post-IPO Debt
Imara
July 2021

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Biopharma · Cambridge$50.0M Post-IPO Equity
Caribou Biosciences
July 2023

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Biotechnology · Berkeley$125.0M Post-IPO Equity
Rhythm Pharmaceuticals
July 2025

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Biotechnology · Boston$175.0M Post-IPO Equity
Mozart Therapeutics
June 2023

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology · Seattle$25.0M Series A
Engine Biosciences
June 2026

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI) · SingaporeVenture - Series Unknown
Oblenio Bio
June 2026

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Biopharma · Oakland$62.0M Series B
DEM BioPharma
June 2022

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Biotechnology · Cambridge$70.0M Series A
Cour Pharmaceuticals Development
June 2026

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Biotechnology · Skokie$50.0M Series B
Zentalis Pharmaceuticals
June 2023

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Biopharma · New York$235.5M Post-IPO Equity
ORIC Pharmaceuticals
May 2025

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Biopharma · South San Francisco$125.0M Post-IPO Equity
Quince Therapeutics
May 2026

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Biotechnology · South San Francisco$115.0M Post-IPO Equity
Valneva
April 2026

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Biotechnology · Saint-herblain$43.1M Post-IPO Equity
Vedanta Biosciences
April 2024

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

Biotechnology · Cambridge$3.9M Grant
Allogene Therapeutics
April 2026

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Biotechnology · South San Francisco$200.4M Post-IPO Equity
DAIVIN
March 2026

Daivin is an oxygen-generating equipment manufacturing company which helps humans breathe underwater without oxygen tanks.

Aerospace · San FranciscoPre-Seed
Flare Therapeutics
March 2023

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Biopharma · Cambridge$123.0M Series B

Where Pfizer invests

Biotechnology22
Therapeutics11
Health Care10
Pharmaceutical9
Biopharma7
Medical5

About Pfizer's portfolio

How many companies has Pfizer invested in?▸

Pfizer has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Pfizer invest in?▸

Pfizer's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Biopharma. The firm invests across 24 different industry categories.

What is Pfizer's largest investment?▸

Among tracked funding rounds, Zentalis Pharmaceuticals received $235.5M in a Post-IPO Equity round. Pfizer's total known invested capital is $4.0B.

What is the average investment size for Pfizer?▸

Pfizer's average investment size is $92.6M across its portfolio of 99 companies.

What are Pfizer's most recent investments?▸

Recent Pfizer portfolio additions include Circle Pharma, ReCode Therapeutics, Levicept, Anjarium Biosciences, Resistell AG. These companies were founded in 2020 or later.

Reach the founders behind these 99 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →